Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects

INTRODUCTION: The aims of this study were to characterize the multiple-dose pharmacokinetics (PK) of ozanimod’s major active metabolites (CC112273 and CC1084037) and to evaluate the pharmacodynamic and PK interactions with pseudoephedrine (PSE). METHODS: In this phase 1, single-center, randomized, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Jonathan Q., Zhang, Peijin, Walker, Susan, Ghosh, Atalanta, Syto, Mary, Wang, Xiaomin, Harris, Sarah, Palmisano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595987/
https://www.ncbi.nlm.nih.gov/pubmed/33025342
http://dx.doi.org/10.1007/s12325-020-01500-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595987/
https://www.ncbi.nlm.nih.gov/pubmed/33025342
http://dx.doi.org/10.1007/s12325-020-01500-0

Ejemplares similares